Aayush Agrawal, acting on behalf of the Aayush Agrawal Trust and as a promoter of Ajanta Pharma, has announced the creation of a pledge on 3,85,000 equity shares. The strategic move, finalized on March 30, 2026, was executed to facilitate an increase in loan facilities. This disclosure reflects the promoter’s ongoing financial activities and adherence to transparency standards regarding shareholding encumbrances.
Details of the Share Pledge
As per the latest regulatory filing, the pledge involves 3,85,000 shares held by the Aayush Agrawal Trust. This transaction represents approximately 0.31% of the total share capital of the company. The encumbrance was officially established on March 30, 2026, with the shares being pledged in favor of Jio credit Ltd to support the promoter’s objective of increasing the current loan facility.
Impact on Promoter Shareholding
Following this transaction, the post-event holding of encumbered shares for the Aayush Agrawal Trust now stands at 87,81,662 shares, which accounts for 7.03% of the total share capital of Ajanta Pharma. The creation of this pledge is categorized as a standard financial undertaking by the promoter group to optimize their existing credit lines.
Context of the Announcement
The disclosure, issued on March 31, 2026, underscores the commitment of the promoter group to maintain transparency regarding changes in their shareholding patterns. While the shares are encumbered, the underlying ownership remains with the Aayush Agrawal Trust, ensuring continuity in the promoter group’s overall involvement with the company.
Source: BSE
